These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8764369)

  • 1. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
    Thomas WL; Cooke ES; Hammer RP
    J Pharmacol Exp Ther; 1996 Jul; 278(1):347-53. PubMed ID: 8764369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    Pierce RC; Born B; Adams M; Kalivas PW
    J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
    Unterwald EM; Ho A; Rubenfeld JM; Kreek MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1387-96. PubMed ID: 7932193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD
    Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids.
    Kunko PM; French D; Izenwasser S
    J Pharmacol Exp Ther; 1998 Apr; 285(1):277-84. PubMed ID: 9536022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
    Trugman JM; Arnold WS; Touchet N; Wooten GF
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1156-60. PubMed ID: 2674418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat.
    Schmidt HD; Anderson SM; Pierce RC
    Eur J Neurosci; 2006 Jan; 23(1):219-28. PubMed ID: 16420431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
    Morelli M; Pontieri FE; Linfante I; Orzi F; Di Chiara G
    Synapse; 1993 Mar; 13(3):264-9. PubMed ID: 8098880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with a dopamine D1-receptor antagonist prevents metabolic activation by cocaine.
    Thomas WL; Cooke ES; Hammer RP
    Neurosci Lett; 1995 Aug; 196(3):161-4. PubMed ID: 7501273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain differences in the effects of adrenalectomy on the midbrain dopamine system: implication for behavioral sensitization to cocaine.
    de Jong IE; Steenbergen PJ; de Kloet ER
    Neuroscience; 2008 May; 153(3):594-604. PubMed ID: 18420350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extrapyramidal regions of rat brain.
    Hammer RP; Cooke ES
    J Neurosci; 1994 Jul; 14(7):4289-98. PubMed ID: 8027779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.